The ability of a cytomegalovirus ELISPOT assay to predict outcome of low-level CMV reactivation in hematopoietic cell transplant recipients

Lynn El Haddad, Ella Ariza-Heredia, Dimpy P. Shah, Ying Jiang, Ted Blanchard, Shashank S. Ghantoji, Firas El Chaer, Danielle El-Haddad, Amrita Prayag, Lior Nesher, Katy Rezvani, Elizabeth Shpall, Roy F. Chemaly

Research output: Contribution to journalArticlepeer-review

18 Scopus citations

Fingerprint

Dive into the research topics of 'The ability of a cytomegalovirus ELISPOT assay to predict outcome of low-level CMV reactivation in hematopoietic cell transplant recipients'. Together they form a unique fingerprint.

Medicine & Life Sciences